MR Solutions’ Liquid Helium Free PET-MRI System Firmly on the Agenda at WMIC

Section 2

Northwell Health Sends Vaccinators to Ecuador

At the request of Ecuador’s Minster of Health, and for the first time since the start of the pandemic, the Northwell Health CGH team traveled outside of the U.S. on June 13 to help get shots in arms relieve overburdened health care workers in the South American country who have been working around the clock in the race to vaccinate their population.

Fusion Marketplace Changes Healthcare Traveler Experience

Fusion Marketplace is a traveler-first driven platform giving healthcare professionals the power to make decisions in their careers that they haven't been able to in the past.

MR Solutions’ latest liquid helium free PET-MR preclinical imaging system for the molecular research community was the subject of talks and papers on simultaneous PET-MR imaging at the World Molecular Imaging Congress held in Montreal in September. Combined PET-MR imaging is becoming the standard for new scanners in preclinical research.

The Mallinckrodt Institute of Radiology (MIR) at Washington University School of Medicine discussed their experience and initial studies following the installation of MR Solutions’ PET-MR dual field 3T/7T scanner. One of their studies was also outlined in a separate poster session[i] where research using MR Solutions’ 7T MRI scanner was discussed.

MR Solutions’ latest PET-MR imaging system for molecular research provides dual scanning capability which significantly improves the quality of the images and the length of time normally taken to conduct separate imaging studies. The PET-MRI capability can be through MR Solutions’ clip on PET scanner for sequential scanning or within the bore for simultaneous scanning.

PET-MRI is highly effective for the imaging of tumours, hearts and brains in rodents for oncology, cardiology and neurology research. The liquid helium free PET-MRI system combines high field 3T to 9.4T MRI imaging for the exquisite structural and functional characterisation of tissue with the extreme sensitivity of PET imaging for metabolism and tracking of uniquely labelled cell types or cell receptors. The imaging results have the best spatial resolution on the market at <0.7mm.

For simultaneous imaging, the PET capability is provided by solid state detectors which are incorporated within the bore of the MRI scanner. To complete the simultaneous imaging, the images are fused together in real time to give a much more detailed image of the animal with the advantages of both scanning techniques.

MR Solutions received the prestigious Queen’s Award for Enterprise 2019 in recognition of the company’s innovative PET imaging technology for use in preclinical research. The company also supplies a clip-on PET module for sequential scanning which can also be used independently as a stand-alone scanner.

Fabrice Chaumard, Sales & Marketing Director at MR Solutions said, “We are thrilled that our PET-MR technology is now becoming the standard in PET-MR imaging. We are seeing a rapid increase not only in enquiries but being the scanning solution in published research papers. There is rapid acceptance and growth for this within the research community and we are continuing to innovate in this area.”

The World Molecular Imaging Congress (WMIC) is organised by the World Molecular Imaging Society (WMIS), and is led by senior academic and industry professionals who are exemplars from the molecular imaging community. Previous events have been held across the world in Seattle, Philadelphia, New York, Honolulu, Korea, France, Canada, Japan, California, Ireland and Georgia.

MR Solutions is the world technology leader in preclinical, liquid helium free MRI scanners with multi-modality capability in PET and SPECT. Recently it has very successfully added CT scanners to its range. All MR Solutions’ scanners use common animal bed and other animal handling solutions to speed up transfers and help reduce costs.  The company which is headquartered in the UK, has offices in North America and a network of technical support people and organisations across the world.

[i] Poster session held on 4 September 2019: ‘Impact of tumor volume, image noise and spatial resolution on radiomics features extracted from T1 and T2 weighted co-clinical MR Images’.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles